217 related articles for article (PubMed ID: 21917686)
1. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.
Dong HY; Weisberger J; Liu Z; Tugulea S
Am J Clin Pathol; 2009 Apr; 131(4):586-95. PubMed ID: 19289595
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity.
Rozenvald IB; Richardson MD; Brock L; Maiese RL
Arch Pathol Lab Med; 2017 Jun; 141(6):837-840. PubMed ID: 28418282
[TBL] [Abstract][Full Text] [Related]
5. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
[TBL] [Abstract][Full Text] [Related]
8. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.
Morgan EA; Yu H; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2013 Feb; 139(2):220-30. PubMed ID: 23355207
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of hairy cell leukemia by flow cytometry.
Stetler-Stevenson M; Tembhare PR
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
[TBL] [Abstract][Full Text] [Related]
13. Hairy cell leukemia variant: fact or fiction.
Cessna MH; Hartung L; Tripp S; Perkins SL; Bahler DW
Am J Clin Pathol; 2005 Jan; 123(1):132-8. PubMed ID: 15762289
[TBL] [Abstract][Full Text] [Related]
14. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
[TBL] [Abstract][Full Text] [Related]
15. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
16. Atypical hairy cell leukemia.
Wu ML; Kwaan HC; Goolsby CL
Arch Pathol Lab Med; 2000 Nov; 124(11):1710-3. PubMed ID: 11079033
[TBL] [Abstract][Full Text] [Related]
17. Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
Arons E; Zhou H; Sokolsky M; Gorelik D; Potocka K; Davies S; Fykes E; Still K; Edelman DC; Wang Y; Meltzer PS; Raffeld M; Wiestner A; Xi L; Wang HW; Stetler-Stevenson M; Yuan C; Kreitman RJ
PLoS One; 2020; 15(2):e0227586. PubMed ID: 32040482
[TBL] [Abstract][Full Text] [Related]
18. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
19. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
20. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.
Pillai V; Pozdnyakova O; Charest K; Li B; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2013 Oct; 140(4):536-43. PubMed ID: 24045551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
